Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,316 | -5,978 | -4,557 | -2,639 | -1,132 |
| Depreciation Amortization | 97 | 374 | 277 | 183 | 92 |
| Accounts receivable | -616 | -215 | -402 | -338 | -708 |
| Other Working Capital | -219 | -379 | -483 | -171 | -664 |
| Other Operating Activity | 710 | 837 | 848 | 449 | 738 |
| Operating Cash Flow | $-1,344 | $-5,361 | $-4,317 | $-2,516 | $-1,674 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -51 | -27 | -27 | -21 |
| Purchase Sale Intangibles | N/A | -64 | -64 | -48 | -42 |
| Other Investing Activity | 0 | -64 | -64 | -48 | -42 |
| Investing Cash Flow | $N/A | $-115 | $-91 | $-75 | $-63 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -81 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $-81 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -6 | 8 | 8 | 6 | 6 |
| Beginning Cash Position | 4,170 | 9,719 | 9,719 | 9,719 | 9,719 |
| End Cash Position | 2,820 | 4,170 | 5,319 | 7,134 | 7,988 |
| Net Cash Flow | $-1,350 | $-5,549 | $-4,400 | $-2,585 | $-1,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,344 | -5,361 | -4,317 | -2,516 | -1,674 |
| Capital Expenditure | N/A | -51 | -27 | -27 | -21 |
| Free Cash Flow | -1,344 | -5,412 | -4,344 | -2,543 | -1,695 |